Sciele Pharma – Amended and Restated Employment Agreement (September 3rd, 2008)
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this Agreement) is made and entered into as of the first day of September, 2008, by and between Sciele Pharma, Inc., a Delaware corporation (the Company), and Leslie Zacks (Executive), and shall become effective as of the Effective Date (as defined below).
Sciele Pharma – Sciele Pharma, Inc. Executives' Compensation for 2007 Summary Sheet (February 29th, 2008)
Sciele Pharma – Amended and Restated Manufacturing and Supply Agreement (February 28th, 2006)
THIS AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT (the Agreement) made as of January 1, 2004 (the Effective Date), by and between FIRST HORIZON PHARMACEUTICAL CORPORATION (First Horizon), a Delaware corporation, having offices at 6195 Shiloh Road, Alpharetta, Georgia, USA, 30005, and PATHEON INC. (Patheon), a corporation existing under the laws of Canada having its registered office at 7070 Mississauga Road, Suite 350, Mississauga, Ontario, L5N 7J8.
Sciele Pharma – Lease Agreement (February 28th, 2006)
THIS LEASE AGREEMENT (this Lease), made this 7th day of February, 2006, by and between 485 PROPERTIES, LLC (Landlord), a Delaware limited liability company, which has as its address for all purposes hereunder as follows:
Sciele Pharma – Amendment to New Distribution Agreement (February 28th, 2006)
This Amendment to the New Distribution Agreement dated October 1, 2004 is made this December 7, 2005 and effective as of January 1, 2006, between First Horizon Pharmaceutical Cayman Limited (FIRST HORIZON CAYMAN), First Horizon Pharmaceutical Corporation (FIRST HORIZON USA) and Bayer Healthcare Aktiengesellschaft (BAYER).
Sciele Pharma – License Agreement Between Andrx Labs, Llc Andrx Laboratories (Nj), Inc. Andrx Pharmaceuticals, Inc. And Andrx Eu Ltd (Collectively, the Licensor) and First Horizon Pharmaceutical Corporation (The Licensee) (May 6th, 2005)
This License Agreement ("Agreement") is effective as of March , 2005 by and between ANDRX LABS, LLC, a Delaware limited liability company, ANDRX LABORATORIES (NJ), INC. a Delaware corporation, ANDRX PHARMACEUTICALS, INC., a Florida corporation, and ANDRX EU, LTD., a United Kingdom company, (hereinafter referred to collectively as "LICENSOR"), and FIRST HORIZON PHARMACEUTICAL CORPORATION, a Delaware corporation (hereinafter "LICENSEE").
Sciele Pharma – Manufacturing and Supply Agreement (May 6th, 2005)
This Manufacturing and Supply Agreement (this "Agreement") is effective as of March 28, 2005 (the "Effective Date"), by and between First Horizon Pharmaceutical Corporation, a Delaware corporation with its principal place of business located at 6195 Shiloh Road, Alpharetta, Georgia 30005 ("Purchaser") and Andrx Pharmaceuticals, Inc., a Florida corporation with its principal office located at 4955 Orange Drive, Davie, Florida 33314 ("Andrx").
Sciele Pharma – First Horizon Pharmaceutical Corporation Executive Officers' Compensation for 2004 and 2005 Summary Sheet (March 11th, 2005)
The target bonus is discretionary and actual amounts paid may be more or less. There is no stated maximum bonus. In 2004, Fourteau, Borne, Mavrogordato, Roberts were paid bonuses of $150,750, $107,200, $30,000, and $31,250 respectively.
Sciele Pharma – Employment Agreement (March 11th, 2005)
This AGREEMENT is made and entered into as of the 30th day of December, 2004, by and between FIRST HORIZON PHARMACEUTICAL CORPORATION, a Delaware corporation (the "Company"), and Leslie B. Zacks ("Executive").